标题
Recent progress in GM-CSF-based cancer immunotherapy
作者
关键词
-
出版物
Immunotherapy
Volume 9, Issue 4, Pages 347-360
出版商
Future Medicine Ltd
发表日期
2017-03-17
DOI
10.2217/imt-2016-0141
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- GM-CSF: From Growth Factor to Central Mediator of Tissue Inflammation
- (2016) Burkhard Becher et al. IMMUNITY
- Beyond antigens and adjuvants: formulating future vaccines
- (2016) Tyson J. Moyer et al. JOURNAL OF CLINICAL INVESTIGATION
- Fusion cytokine IL-2-GMCSF enhances anticancer immune responses through promoting cell–cell interactions
- (2016) Qian Wen et al. Journal of Translational Medicine
- Immunology of chronic myeloid leukemia: current concepts and future goals
- (2015) Vladimír Vonka et al. Expert Review of Clinical Immunology
- Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group–American College of Radiology Imaging Network Cancer Research Group (E4697)
- (2015) David H. Lawson et al. JOURNAL OF CLINICAL ONCOLOGY
- Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma
- (2015) Robert H.I. Andtbacka et al. JOURNAL OF CLINICAL ONCOLOGY
- Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting
- (2015) Evan J Lipson et al. Journal of Translational Medicine
- Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial
- (2015) Encouse B Golden et al. LANCET ONCOLOGY
- A novel recombinant protein of ephrinA1–PE38/GM-CSF activate dendritic cells vaccine in rats with glioma
- (2015) Ming Li et al. TUMOR BIOLOGY
- Ex vivo generation of myeloid-derived suppressor cells that model the tumor immunosuppressive environment in colorectal cancer
- (2015) Inès Dufait et al. Oncotarget
- In Situ Modulation of Dendritic Cells by Injectable Thermosensitive Hydrogels for Cancer Vaccines in Mice
- (2014) Yarong Liu et al. BIOMACROMOLECULES
- A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN)
- (2014) Dan P. Zandberg et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Discovery of Mesothelin and Exploiting It as a Target for Immunotherapy
- (2014) I. Pastan et al. CANCER RESEARCH
- Engineering α-fetoprotein-based gene vaccines to prevent and treat hepatocellular carcinoma: review and future prospects
- (2014) Yukai He et al. Immunotherapy
- Ipilimumab Plus Sargramostim vs Ipilimumab Alone for Treatment of Metastatic Melanoma
- (2014) F. Stephen Hodi et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Activated Lymphocyte Recruitment Into the Tumor Microenvironment Following Preoperative Sipuleucel-T for Localized Prostate Cancer
- (2014) Lawrence Fong et al. JNCI-Journal of the National Cancer Institute
- Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy
- (2014) Jaeyun Kim et al. NATURE BIOTECHNOLOGY
- Therapeutic vaccines for cancer: an overview of clinical trials
- (2014) Ignacio Melero et al. Nature Reviews Clinical Oncology
- Current status of granulocyte–macrophage colony-stimulating factor in the immunotherapy of melanoma
- (2014) Howard L Kaufman et al. Journal for ImmunoTherapy of Cancer
- The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer
- (2013) Nicola E. Annels et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Signalling by the βc family of cytokines
- (2013) Timothy R. Hercus et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Cancer vaccines targeting carcinoembryonic antigen: state-of-the-art and future promise
- (2013) Sofia R Gameiro et al. Expert Review of Vaccines
- An update on vaccine therapy and other immunotherapeutic approaches for glioblastoma
- (2013) David A Reardon et al. Expert Review of Vaccines
- Tumor lysate-loaded biodegradable microparticles as cancer vaccines
- (2013) Vijaya B Joshi et al. Expert Review of Vaccines
- Successes, failures and new perspectives of idiotypic vaccination for B-cell non-Hodgkin lymphomas
- (2013) Elena Muraro et al. Human Vaccines & Immunotherapeutics
- Regulation of dendritic cell development by GM-CSF: molecular control and implications for immune homeostasis and therapy
- (2012) L. van de Laar et al. BLOOD
- Immune-Dependent and Independent Antitumor Activity of GM-CSF Aberrantly Expressed by Mouse and Human Colorectal Tumors
- (2012) R. G. Urdinguio et al. CANCER RESEARCH
- Vaccines in non-small cell lung cancer: Rationale, combination strategies and update on clinical trials
- (2012) Tommaso De Pas et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- A Lethally Irradiated Allogeneic Granulocyte-Macrophage Colony Stimulating Factor-Secreting Tumor Vaccine for Pancreatic Adenocarcinoma
- (2011) Lutz Eric et al. ANNALS OF SURGERY
- PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
- (2011) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Spontaneous antibody, and CD4 and CD8 T-cell responses against XAGE-1b (GAGED2a) in non-small cell lung cancer patients
- (2011) Yoshihiro Ohue et al. INTERNATIONAL JOURNAL OF CANCER
- Vaccination With Patient-Specific Tumor-Derived Antigen in First Remission Improves Disease-Free Survival in Follicular Lymphoma
- (2011) Stephen J. Schuster et al. JOURNAL OF CLINICAL ONCOLOGY
- Cancer immunotherapy comes of age
- (2011) Ira Mellman et al. NATURE
- Cellular Vaccine Approaches
- (2010) Dung T. Le et al. CANCER JOURNAL
- 5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity
- (2010) J. Vincent et al. CANCER RESEARCH
- K562/GM-CSF Immunotherapy Reduces Tumor Burden in Chronic Myeloid Leukemia Patients with Residual Disease on Imatinib Mesylate
- (2010) B. D. Smith et al. CLINICAL CANCER RESEARCH
- Inhaled Granulocyte-Macrophage Colony Stimulating Factor for First Pulmonary Recurrence of Osteosarcoma: Effects on Disease-Free Survival and Immunomodulation. A Report From the Children's Oncology Group
- (2010) C. A. S. Arndt et al. CLINICAL CANCER RESEARCH
- A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers
- (2010) K. N. Kodumudi et al. CLINICAL CANCER RESEARCH
- GM-CSF–dependent, CD103+dermal dendritic cells play a critical role in Th effector cell differentiation after subcutaneous immunization
- (2010) Irah L. King et al. JOURNAL OF EXPERIMENTAL MEDICINE
- DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) Elicits Long-term T-cell Responses in Patients With Recurrent Prostate Cancer
- (2010) Jordan T. Becker et al. JOURNAL OF IMMUNOTHERAPY
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of GM-CSF signaling in cell-based tumor immunization
- (2009) S. Zarei et al. BLOOD
- The granulocyte-macrophage colony-stimulating factor receptor: linking its structure to cell signaling and its role in disease
- (2009) T. R. Hercus et al. BLOOD
- GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells
- (2009) Johanna K. Morales et al. BREAST CANCER RESEARCH AND TREATMENT
- A phase II study of oxaliplatin, docetaxel, and GM-CSF in patients with previously treated advanced melanoma
- (2009) Frederick Locke et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Vaccination with an Allogeneic Whole-Cell Melanoma Vaccine
- (2009) M. B. Faries et al. CLINICAL CANCER RESEARCH
- Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Circulating CD8+ and CD4+ T-Cell Responses to a Multipeptide Melanoma Vaccine: Outcome of a Multicenter Randomized Trial
- (2009) C. L. Slingluff et al. CLINICAL CANCER RESEARCH
- Placebo-Controlled Phase III Trial of Patient-Specific Immunotherapy With Mitumprotimut-T and Granulocyte-Macrophage Colony-Stimulating Factor After Rituximab in Patients With Follicular Lymphoma
- (2009) Arnold Freedman et al. JOURNAL OF CLINICAL ONCOLOGY
- Feedback control of regulatory T cell homeostasis by dendritic cells in vivo
- (2009) Guillaume Darrasse-Jèze et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Recombinant Human Granulocyte-macrophage Colony-stimulating Factor (GM-CSF, Sargramostim) Administered for 3 Years as Adjuvant Therapy of Stages II(T4), III, and IV Melanoma
- (2009) Lynn E. Spitler et al. JOURNAL OF IMMUNOTHERAPY
- In Situ Regulation of DC Subsets and T Cells Mediates Tumor Regression in Mice
- (2009) O. A. Ali et al. Science Translational Medicine
- A Dose-Escalation Study of Aerosolized Sargramostim in the Treatment of Metastatic Melanoma
- (2008) Svetomir N. Markovic et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Hematopoietic cytokines
- (2008) D. Metcalf BLOOD
- Phase 1/2 dose-escalation study of a GM-CSF-secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer
- (2008) Celestia S. Higano et al. CANCER
- Phase I/II Study of GM-CSF DNA as an Adjuvant for a Multipeptide Cancer Vaccine in Patients With Advanced Melanoma
- (2008) Miguel-Angel Perales et al. MOLECULAR THERAPY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started